Japan· JP-3999447D1020
コンドリアーゼ
A medicinal product containing コンドリアーゼ, registered in Japan by 生化学工業, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- コンドリアーゼ
- Manufacturer
- 生化学工業
- Country
- Japan (JP)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- October 2, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
コンドリアーゼ in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NorwayVimizimOrifarm AS
- United KingdomVimizim 5mg/5ml concentrate for solution for infusion vialsBioMarin (U.K.) Ltd
- SwitzerlandVimizim 5mg/5ml, Konzentrat zur Herstellung einer InfusionslösungDRAC AG
- CzechiaVIMIZIMBioMarin International Limited, Dublin
- SpainVIMIZIM 1MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSIONBiomarin International Limited
- FinlandVimizimBiomarin International Limited
- FranceVIMIZIM 1 mg/ml, solution à diluer pour perfusionBIOMARIN INTERNATIONAL LIMITED (IRLANDE)
- IrelandVimizim 1 mg/ml concentrate for solution for infusionBiomarin International Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Vimizim
- Liechtenstein · Vimizim
- Norway · Vimizim
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b5abd9f1-290f-44cd-953b-f101c454cd52 GET /v1/drugs/b5abd9f1-290f-44cd-953b-f101c454cd52?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "１．２５単位１瓶",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "3999447D1020",
"category": "注射薬",
"price_yen": 83189,
"generic_name": "コンドリアーゼ",
"product_name_jp": null,
"therapeutic_class": "3999",
"transitional_expiry": null
}See everything about コンドリアーゼ.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.